BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Achyut Healthcare Ltd. Share Price

NSE
BSE

BSE : 543499

Sector : Trading

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹6.48
Day's Range ₹6.42 - ₹6.86
Open ₹6.51
52 Week Range ₹03.90 - ₹10.04
Volume 21,444
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 1.42
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 493.37
TTM EPS (₹) 0.01
P/E Ratio 140.21
Book Value(₹) 4.46
PAT Margin (%) 17.97
Face Value (₹) 1.00
ROCE(%) 2.27

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 30.48 9.21
Expenses N/A N/A
PBT 6.51 1.26
Operating profit 0.0 0.0
Net profit 5.15 1.21

Shareholding Pattern

Promoters (% Holding)

47.32%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

47.55%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

5.13%

About Achyut Healthcare Ltd.

Founded 1996
Managing Director Jigen Jagdishbhai Modi

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Adani Enterprises Ltd. 4,07,267.44 3,008.50 1,753.00 - 1,753.00
Premier Energies Ltd. 46,300.78 1,019.95 660.00 - 660.00
Aegis Logistics Ltd. 44,978.90 1,281.45 576.10 - 576.10
Aditya Infotech Ltd. 39,959.56 3,396.00 0.00 - 0.00
Redington Ltd. 25,145.77 321.65 191.31 - 191.31
Honasa Consumer Ltd. 14,658.05 449.95 248.40 - 248.40
Lloyds Enterprises Ltd. 12,279.58 80.05 40.69 - 40.69
MMTC Ltd. 9,396.00 62.64 50.10 - 50.10
SG Mart Ltd. 8,788.43 694.15 313.10 - 313.10
Cello World Ltd. 7,573.04 344.00 336.60 - 336.60
no-content No Records Found

Latest News

Jul
15
2026
EQUITY Posted on Jul 15th 2026

Achyut Healthcare informs about outcome of board meeting

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’), Achyut Healthcare has informed that the Board of Directors of the Company, at its meeting held today July 14, 2026 (Tuesday) at the registered office of the Company, after considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company, has considered and approved a Scheme of Amalgamation of Achyut Healthcare (‘Transferor Company’) with and into Zenith Healthcare (‘Transferee Company’) and their respective shareholders and creditors (‘Scheme’), under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (‘Act’), rules and regulations made thereunder read with Section 2(6) of the Income Tax Act, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. The Scheme is subject to requisite approvals and sanction of the appropriate statutory and regulatory authorities including jurisdictional bench of the National Company Law Tribunal (‘NCLT’) and subject to the approval of shareholders and/or creditors. Further, the Scheme shall be filed with BSE for obtaining the no-objection letter/ observation letter in terms of Regulation 37(1) of the SEBI LODR Regulations read with SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023. The details / information as required under Regulation 30 of the SEBI LODR Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding the Scheme are enclosed as ‘Annexure – A’. The aforesaid meeting of the Board of Directors of the Company commenced at 7.05 PM and concluded at 7.50 PM.

The above information is a part of company’s filings submitted to BSE.

Read More
Aug
1
2026
EQUITY Posted on Aug 1st 2026

Biofil Chemicals & Pharmaceuticals submits board meeting intimation

Biofil Chemicals & Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026, to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June, 2026 along with Limited Review Report thereon; and to consider other routine matters with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
1
2026
EQUITY Posted on Aug 1st 2026

Rekvina Laboratories informs about updates

Rekvina Laboratories has informed that the company is in receipt of enclosed Post-Offer Advertisement of offer issued by Vivro Financial Services in relation to the Open Offer to the Public Shareholders of the company.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
1
2026
EQUITY Posted on Aug 1st 2026

The Yamuna Syndicate informs about newspaper advertisement

Pursuant to Regulation 30, 47 read with Schedule III and any other applicable regulation(s) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, The Yamuna Syndicate has informed that the Company has published a public notice in Business Standard (English daily newspaper all edition) and Business Standard (Hindi daily newspaper) dated August 01, 2026, intimating E-voting process, cut-off date and Record date for dividend, for the 72nd Annual General Meeting dated August 24, 2026. Copies of the said advertisements are enclosed. This intimation is also being uploaded on the website of the Company at www.yamunasyndicate.com under section: https://yamunasyndicate.com/advertisement/.

The above information is a part of company’s filings submitted to BSE.

Read More
Aug
1
2026
EQUITY Posted on Aug 1st 2026

Parshva Enterprises submits board meeting intimation

Parshva Enterprises has informed that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026, to consider and approve the Un-Audited Consolidated and Standalone Financial Results for the Quarter ended June 30, 2026 along with Limited review Report thereon; and any other matter with permission of chair, if any. As informed earlier, pursuant to the Company's Code of conduct for Prohibition of Insider Trading, the trading window for dealing in securities of the Company will remain closed for all the directors/ officers/ designated employees/ Connected Persons of the Company from 1st July, 2026 to 8th August, 2026. This notice is being submitted pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time.
The above information is a part of company's filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Achyut Healthcare Ltd. ?

The current share price of Achyut Healthcare Ltd. is ₹6.48 as of 2026-07-31.

The market capitalisation of Achyut Healthcare Ltd. is ₹156.40 as of 2026-07-31.

The 1-year return of Achyut Healthcare Ltd. is 2.25% as of 2026-07-31.

The P/E ratio of Achyut Healthcare Ltd. is 140.21 as of 2026-08-02.

The 52-week high and low of Achyut Healthcare Ltd. are ₹10.04 and ₹3.90, respectively, as of 2026-07-31.

The dividend yield of Achyut Healthcare Ltd. is 0.0% as of2026-07-31.

You can buy Achyut Healthcare Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Achyut Healthcare Ltd. is Jigen Jagdishbhai Modi.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore